BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/28/2026 1:16:30 PM | Browse: 9 | Download: 0
Publication Name World Journal of Diabetes
Manuscript ID 122293
DOI 10.4239/wjd.122293
Country China
Category Endocrinology & Metabolism
Manuscript Type Review
Article Title Targeting gut microbiota: Potential mechanisms in the pathogenesis of type 2 diabetes mellitus and emerging translational intervention strategies
Manuscript Source Unsolicited Manuscript
All Author List Fu-Jian Xie, Miao Zhang, Wan-Ting Li, Wei-Ye Zhou, Hai-Bei Ma, Yu Xu and Li-Ming Bi
Funding Agency and Grant Number
Funding Agency Grant Number
Wuxi “Double Hundred” Young and Middle-aged Medical Top Talents Program No. BJ2023065
Jiangsu Provincial Administration of Traditional Chinese Medicine No. ZZYB21
Corresponding Author Li-Ming Bi, PhD, Department of Traditional Chinese Medicine Classics, Wuxi Affiliated Hospital of Nanjing University of Chinese Medicine, No. 8 Zhongnan West Road, Binhu District, Wuxi 214071, Jiangsu Province, China. biliming00@aliyun.com
Key Words Type 2 diabetes mellitus; Gut microbiota; Traditional Chinese medicine; Treatment; Metabolic diseases
Core Tip Increasing evidence indicates that gut microbiota plays a critical role in the development of type 2 diabetes mellitus (T2DM). Unlike previous reviews that primarily focus on microbial compositional alterations, this review highlights that functional dysregulation of the gut microbiota is the central driver of T2DM pathogenesis. We propose an integrated metabolic-immune-barrier-endocrine framework linking microbial metabolites, inflammation, intestinal barrier dysfunction, and endocrine signaling to glucose dysregulation. We further summarize emerging microbiota-targeted interventions and their translational potential for personalized T2DM management.
Citation Xie FJ, Zhang M, Li WT, Zhou WY, Ma HB, Xu Y, Bi LM. Targeting gut microbiota: Potential mechanisms in the pathogenesis of type 2 diabetes mellitus and emerging translational intervention strategies. World J Diabetes 2026; In press
PDF 122293-in-press.pdf
Received
2026-04-17 00:31
Peer-Review Started
2026-04-22 08:59
First Decision by Editorial Office Director
Return for Revision
2026-06-17 08:23
Revised
2026-07-01 05:55
Publication Fee Transferred
2026-07-20 01:41
Second Decision by Editor
2026-07-24 03:17
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-07-28 13:16
Articles in Press
2026-07-28 13:16
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-9358 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com